Pomerantz LLP is investigating claims on behalf of investors of Axon Enterprise, Inc. ("Axon" or the "Company") (NASDAQ: AAXN). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 9980.
The investigation concerns whether Axon and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On October 19, 2017, post-market, Axon announced that the U.S. Securities and Exchange Commission ("SEC") is reviewing the Company's financial filings. Specifically, Axon has received three letters from the SEC requesting additional information regarding Axon's 2016 annual report and the Company's quarterly report for the first quarter of 2017. Axon advised investors that Axon only recently became aware of the SEC's letters, the earliest of which was dated August 10, 2017. The SEC's third letter to Axon, dated September 20, 2017, informed the Company that the SEC's inquiries were "outstanding and unresolved, and absent a substantive response, we would act consistent with our obligations under the federal securities laws."
On this news, Axon's share price has fallen as much as $1.62, or 6.58%, during intraday trading on October 20, 2017.